Neuracle
Neuracle is an Invasive Cortical Implants company founded in 2011 and based in Shanghai, China.
Neuracle, founded in 2011 and headquartered in Shanghai, develops invasive brain-computer interface systems for motor restoration. The company's NEO device is an epidural implant system approved for commercial use in China (NMPA approval, March 2026) that uses eight electrodes placed on the brain's dura mater to decode motor intentions and control a pneumatic robotic glove, enabling hand grasping restoration in patients with cervical spinal cord injuries. Clinical trials involving 36 patients demonstrated sustained function in home-based settings. Neuracle also manufactures NeuSen W, a wireless multichannel EEG acquisition system for research and clinical use. The company operates as a private entity with no disclosed funding data.
Neuracle's NEO system represents a deployed invasive cortical implant approved by a national regulator for commercial use, demonstrating clinical viability in functional restoration for spinal cord injury patients. The company operates at the intersection of neurotechnology and medical device approval, addressing a significant market segment within the brain-computer interface sector. Its dual product portfolio—both invasive implants and supporting research infrastructure—positions it within the growing ecosystem of neurotech commercialization.
neuracle.cn ↗·Invasive Cortical Implants·
China·private 
